乳腺癌患者紧急生育力保存后数年的生育结局
这项双中心回顾性观察队列纳入2013年1月至2019年7月乳腺癌治疗前接受生育力保存的844例患者,649例有治疗后妊娠尝试数据,其中255例尝试受孕,135例(52.9%)获得妊娠,多数为自然受孕(79.3%),99例活产;首次生育力保存咨询后48个月妊娠累积发生率为33.1%。
要点
- 乳腺癌生育力保存后尝试受孕者中52.9%获得妊娠,79.3%为自然受孕。
- 首次生育力保存咨询后48个月妊娠累积发生率为33.1%。
- 仅诊断时多产次和未接受化疗是妊娠的正向预测因素。
核心结论
- 乳腺癌患者生育力保存后的妊娠率虽低,但多数妊娠无需医疗辅助即可实现。
- 研究结果可用于告知女性不同生育力保存技术的疗效与安全性,以及相对较高的自然受孕机会。
研究设计与样本
- 回顾性观察性双中心队列研究,设置于大学医院。
- 纳入2013年1月至2019年7月乳腺癌治疗前接受生育力保存的患者共844例,终点日期为2022年3月1日。
- 排除癌症诊断后妊娠尝试数据缺失的195例,最终649例纳入妊娠分析。
主要发现
- 649例有妊娠尝试数据的患者中,255例(39.3% [35.5-43.2])尝试受孕,中位随访6.5年。
- 255例尝试受孕者中135例(52.9% [46.6-59.2])获得妊娠,其中79.3% [72.8-84.8]为自然受孕,99例报告活产(占尝试受孕者的38.8%)。
- 首次生育力保存咨询后48个月,妊娠累积发生率为33.1% [27.6-37.9]。
- 调整年龄、产次、化疗给药类型和内分泌治疗后,仅诊断时多产次和未接受化疗是乳腺癌后妊娠的正向预测因素。
- 793例玻璃化冻存卵母细胞和胚胎的患者中,68例使用冻存物(占尝试受孕者的27% [21.3-32.5]),获得8例活产(11.8% [5.2-21.9])。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the fertility outcomes of women who tried to conceive after breast cancer (BC) treatment and fertility preservation. DESIGN: Retrospective observational, bicentric cohort study. SETTING: University hospital. PATIENTS: Patients with BC. INTERVENTION: All patients who had undergone fertility preservation before BC treatment between January 2013 and July 2019 were included (n = 844). The endpoint date was March 1, 2022. Patients with missing data on pregnancy attempts after a cancer diagnosis (n = 195) were excluded from the pregnancy analysis. MAIN OUTCOME MEASURES: Cumulative incidences of pregnancy and live birth (LB) were calculated. For women who became pregnant, the time to conception was calculated between the first fertility preservation consultation and the estimated day of conception. For those who did not conceive, we considered the time between the first fertility preservation consultation and the endpoint date, or the date of patient death. A Cox regression model was used to study the predictive factors for pregnancy and LB. RESULTS: Among the 649 patients with available data on pregnancy attempts after BC diagnosis, 255 (39.3% [35.5-43.2]) tried to conceive (median follow-up of 6.5 years). Overall, 135 (52.9% [46.6-59.2]) of these patients achieved a pregnancy, mainly through unassisted conception (79.3% [72.8-84.8]), and 99 reported an LB (representing 38.8% of patients who attempted conception). In our cohort, 48 months after the first fertility preservation consultation, the cumulative incidence of pregnancy was 33.1% ([27.6-37.9]). After adjustment for age, parity, type of chemotherapy administration, and endocrine therapy, only multiparity at diagnosis and absence of chemotherapy were positive predictive factors of pregnancy after cancer. Of the 793 patients who had vitrified oocytes and embryos, 68 used them (27% [21.3-32.5] of the patients who tried to conceive), resulting in 8 LBs (11.8% [5.2-21.9]). Women who used their cryopreserved oocytes and embryos were older at the first consultation of fertility preservation (hazard ratio 1.71 [1.42-2.21]), and chose more often to vitrify embryos (hazard ratio 1.76 [1.28-2.23]). CONCLUSION: Although pregnancy rates after fertility preservation for patients with BC are low, most conceptions are achieved without medical assistance. Our findings provide useful information to advise women on the different techniques of fertility preservation, their efficacy, and safety, as well as the relatively high chances of unassisted conception.
引用
- Peigné M, Mur P, Laup L, et al. Fertility outcomes several years after urgent fertility preservation for patients with breast cancer. Fertil Steril. 2024. PMID: 38679360. doi:10.1016/j.fertnstert.2024.04.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。